A multicenter case-control study in Iran reported that self-reported prolonged mobile phone use was associated with higher odds of confirmed and suspected breast cancer status. The authors emphasize that the findings do not imply causation and note limitations including self-reported exposure and potential residual confounding. They call for larger prospective studies with objective exposure assessment.

This magazine article discusses the rising incidence of thyroid cancer and raises the possibility of an association with increased smartphone use and related RF EMF exposure near the head and neck. It characterizes EMF exposure from personal electronics as a growing public health concern. The piece calls for more research, monitoring, and public awareness, and mentions precautionary measures.

This RF Safe article argues that it is no longer accurate to claim there is no mechanism or no evidence of harm from RF exposure below current limits. It presents a proposed biological framework involving voltage-gated ion channels, oxidative stress pathways, and radical-pair (spin-dependent) chemistry, and cites animal studies (NTP and Ramazzini) and other literature as supporting evidence. The piece frames the remaining uncertainty as the magnitude of human risk rather than whether a hazard exists.

This RF Safe article argues that the “strongest” RF-EMF literature supports concern about cancer-related findings, emphasizing non-monotonic dose–response patterns in the U.S. National Toxicology Program (NTP) rat study and citing additional analyses and animal studies. It reports that FDA evaluations have downplayed the human relevance of NTP results due to high exposures and inconsistencies, and counters that some effects may occur at lower exposure levels than commonly claimed. The piece also references the Ramazzini Institute rat study as supportive evidence at lower whole-body SARs and mentions a 2024 PLOS ONE paper analyzing Ramazzini tumors, but provides limited detail in the excerpt.

RF Safe argues that a shared biological mechanism links RF/ELF exposure to outcomes such as cancer, infertility, autoimmune dysfunction, and metabolic effects. The article proposes that RF/ELF fields disrupt voltage-gated ion channel (VGIC) S4 “timing,” altering calcium signaling and increasing mitochondrial reactive oxygen species (ROS), which then drives tissue-specific damage. It cites mechanistic researchers, major rodent bioassays (NTP, Ramazzini), and WHO-commissioned systematic reviews as converging support, but the piece is presented as advocacy/commentary rather than a new peer-reviewed study.

An RF Safe commentary argues that a proposed “S4–mitochondria axis” provides a coherent mechanism for non-thermal RF/ELF biological effects, linking voltage-gated ion channel (VGIC) disruption to altered calcium signaling, mitochondrial ROS, and downstream cancer, reproductive, and immune impacts. The post cites several recent reviews and systematic reviews (including a WHO-commissioned animal carcinogenicity review and an SR4A corrigendum) as strengthening evidence for specific tumor and reproductive outcomes in animals. It concludes that regulatory positions emphasizing thermal limits and lack of mechanism are no longer defensible, presenting this as convergent evidence rather than scattered findings.

RF Safe argues that findings it describes as “high-certainty” from WHO-commissioned systematic reviews show RF-EMF causes malignant heart Schwannomas and brain gliomas in rodents and reduces male fertility. The post proposes a unifying non-thermal mechanism—the “S4-mitochondria axis”—suggesting RF-EMF interacts with the voltage-sensing S4 helix of voltage-gated ion channels (VGICs) and is amplified by mitochondrial density. It concludes that the combination of animal evidence and a proposed mechanism supports precautionary revisions to exposure guidelines and more mechanistic research.

RF Safe’s “Executive Summary” argues that non-thermal radiofrequency/microwave exposures from modern wireless technologies can disrupt biological processes, proposing ion-channel voltage-sensor interference as a key mechanism leading to oxidative stress and inflammation. It cites animal studies (NTP and Ramazzini) and claims a WHO-commissioned 2025 systematic review found “high certainty” evidence of increased cancer in animals, and it points to epidemiological trends as suggestive. The piece also criticizes U.S. regulation as focused on thermal effects, highlighting FCC limits dating to 1996 and referencing a 2021 U.S. court ruling that faulted the FCC for not addressing non-thermal evidence.

This review argues that EMF exposure is associated in the literature with several adverse central nervous system outcomes, including blood-brain barrier disruption, oxidative stress, neurotransmitter changes, cognitive effects, and neurodevelopmental impacts. It reports that evidence on EMFs and brain tumors is conflicting, while noting WHO’s classification of radiofrequency EMFs as possibly carcinogenic to humans. The authors highlight prenatal and childhood periods as potentially more vulnerable and call for more standardized long-term and mechanistic research to guide public health policy.

This review/technical note discusses whether chronic EMF exposure, mainly from mobile phones and wireless devices, should be reconsidered as a possible risk factor for oral cancer/OSCC. It highlights biological plausibility and reports from pilot cytogenetic and laboratory studies, plus limited epidemiological observations, suggesting increased micronucleus formation and altered stress responses in buccal mucosal cells among long-term users. The authors emphasize that a direct causal link to OSCC is not established and call for more comprehensive research.

This multicenter case-control study in Iran (n=226) examined associations between mobile phone use and breast cancer outcomes in women. Reporting more than 60 minutes/day of phone conversations was associated with higher odds of confirmed invasive breast cancer and of being classified as a suspected case versus <10 minutes/day. The authors emphasize that the results do not establish causation and may be influenced by self-reported exposure and residual confounding, warranting cautious interpretation.

No abstract was provided. From the title and supplied overview, this paper critiques the Mevissen et al. systematic review on RF-EMF exposure and cancer in animal studies, asserting that methodological and analytical flaws led to misjudgment of the evidence. The provided text frames the topic as requiring careful analysis to avoid underestimating potential health risks.

This magazine article reviews the Japan-Korea "NTP Lite" RF animal toxicity collaboration and its relationship to prior NTP (2018) and Ramazzini Institute reports of RF-associated tumors in male rats. It notes NTP Lite used a single whole-body SAR of 4 W/kg and completed a two-year exposure phase in 2022, but final reporting is delayed with histopathology and genotoxicity work ongoing. The author highlights protocol harmonization across labs while raising concerns about unexplained animal deaths and physiological differences in exposed groups, and frames the broader evidence as supportive of RF-related cancer risk in laboratory animals.

This review discusses epidemiological and mechanistic reports linking EMF exposure with oxidative stress and disease risk, and introduces an Electromagnetic Pathogenesis (EMP) conceptual model. The model proposes that non-ionizing EMFs increase mitochondrial electron leakage via electron tunneling, raising free radical production and oxidative stress. The authors argue oxidative stress is a primary mechanism connecting EMF exposure to cancer, cardiovascular, neurodevelopmental/neurodegenerative diseases, and behavioral/reproductive effects, and suggest reducing exposure may lower risk.

This paper evaluates and critiques 12 WHO-commissioned systematic reviews and meta-analyses on RF-EMF health effects across outcomes including cancer and reproductive endpoints. It argues that serious methodological flaws and limitations in the WHO reviews prevent them from providing assurance of safety for cell phones and other wireless devices. The authors highlight reported evidence in the animal cancer review (high certainty for heart schwannomas; moderate certainty for brain gliomas) and describe dose-related adverse effects on male fertility and reproductive outcomes, including at exposure levels below current ICNIRP thresholds.

This review discusses recent studies on microwave and RF exposure and their reported impacts on molecular and cytogenetic materials. It states there is growing evidence that RF exposure can induce DNA damage at levels considered safe by current standards, and cites newly reported genetic alterations in rat cancers after lifetime low-level RF exposure. The article concludes that these findings challenge existing exposure guidelines and support reconsideration of regulatory limits.

This narrative review examines research on radiofrequency electromagnetic radiation (RF-EMR) from mobile towers and its potential association with genetic damage and genetic polymorphism in humans, with an emphasis on India. The abstract states that RF-EMR exposure may affect genetic material and suggests a link between EMR exposure and genetic damage, with possible implications for cancer risk and cell death. It also highlights that genetic polymorphisms may modify susceptibility and calls for further research to clarify health impacts.

This review compares two epidemiologic studies of radio-frequency radiation (RFR) exposure among military personnel with overlapping patient groups. One study reported a statistically significant increase in cancer among exposed individuals, while the other did not, which the review attributes to a smaller sample size. The review highlights similar cancer patterns across both studies, including a high proportion of hematolymphoid cancers and earlier onset among exposed individuals, and interprets these similarities as evidence of carcinogenic effects.